Cephalon Inc – ‘8-K’ for 9/15/98

As of:  Wednesday, 9/23/98   ·   For:  9/15/98   ·   Accession #:  1036050-98-1628   ·   File #:  0-19119

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Form 8-K for Cephalon, Inc.                            4     11K 
 2: EX-99.1     Press Release Dated September 15, 1998                 1      8K 
 3: EX-99.2     Press Release Dated September 18, 1998                 2±    10K 

8-K   —   Form 8-K for Cephalon, Inc.
Document Table of Contents

8-K
1st Page of 4
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
UNITED STATES 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549 

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) 
OF THE SECURITIES EXCHANGE ACT OF 1934

September 15, 1998
--------------------------------- 
(Date of earliest event reported) 

Cephalon, Inc.
----------------------------------------------------- 
(Exact name of registrant as specified in its charter)

Delaware                          0-19119              23-2484489 
--------------------------------------------------------------------------------
(State or other jurisdiction           (Commission          (IRS Employer       
of incorporation or organization)      File Number)          ID No.)            

145 Brandywine Parkway                                            
West Chester, Pennsylvania                             19380      
--------------------------------------------------------------------------------
(Address of principal executive offices)                     (Zip Code)         

(215) 344-0200
--------------------------------------------------
(Registrant's telephone number, including area code)

Not Applicable
 ---------------------------------------------------
(Former name, former address and former fiscal year,
if changed since last report) 

8-K
2nd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 2nd
ITEM 5.  OTHER EVENTS.                                                          
 On September 15, 1998, Cephalon, Inc. (the "Registrant") announced that
Cephalon-Chiron B.V. has withdrawn its application to the European Medicines    
Evaluation Agency (EMEA) seeking clearance to market MYOTROPHIN(R) (mecasermin) 
Injection in Europe for the treatment of amyotrophic lateral sclerosis (ALS or  
motor neuron disease).                                                          

 On September 18, 1998, the Registrant announced the first findings from
preclinical studies of its compound, CEP-701, for the treatment of pancreatic   
ductal adenocarcinoma (PDAC).  The results presented on September 18, 1998 at   
the Baltic Pancreas Meeting in Germany demonstrate that CEP-701 can             
significantly decrease tumor growth as well as inhibit tumor cell invasion in   
PDAC animal models.                                                             

 The Registrant hereby attaches both releases as Exhibits 99.1 and 99.2,
respectively, which are thereby made a part of this Item 5.                     

ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS.                                     

(a) Financial Statements of Business Acquired: None           
------------------------------------------            

(b) Pro Forma Financial Information: None                     
--------------------------------                      

         (c) Exhibits: Reference is made to the Exhibit Index annexed hereto and
--------                                              
made a part hereof.                                                             

8-K
3rd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 3rd
SIGNATURES
----------- 

  Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the        
undersigned thereunto duly authorized.                                          

      CEPHALON, INC.

Date:  September 23, 1998           By: /s/ Bruce A. Peacock                    
     ------------------              ---------------------------------------
              Bruce A. Peacock
                          Executive Vice President and
                     Chief Operating Officer

8-K
Last Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 4th
EXHIBIT INDEX 
------------- 

EXHIBIT                                                           PAGE          
-------                                                           ----          

99.1 Press Release dated September 15, 1998                                     
99.2 Press Release dated September 18, 1998                                     

Dates Referenced Herein

				Referenced-On Page
This ‘8-K’ Filing		Date		First		Last			Other Filings
Filed on:		9/23/98		3					None on these Dates
		9/18/98		2		4
For Period End:		9/15/98		1		2
									List all Filings